MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-UP-56-0004818
Bestochem Formulations (India) Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹66.17 Cr
▲ 5% YoY
Net profit · FY 2024
₹2.47 Cr
Net margin 3.7%
EBITDA · FY 2024
₹4.11 Cr
EBITDA margin 6.2%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.76 Cr
Issued & subscribed
Open charges
₹16.17 Cr
Satisfied ₹32.83 Cr
Company age
41 yrs
Est. 1985
Directors on board
4
As per MCA filings
About Bestochem Formulations (India) Limited
Data last updated:
Bestochem Formulations (India) Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL1985PLC022036. Its GSTIN is 09AACCB2139E1Z1 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.76 Cr. It was formerly known as Bestochem Formulations (India) Private Limited. It is led by directors including Greesh Kumar Juneja and Anita Juneja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 54 Vikas Marglaxmi Nagar, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2024, the company reported a revenue of ₹66.17 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹2.47 Cr (net margin 3.7%) and EBITDA of ₹4.11 Cr (EBITDA margin 6.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
The company is associated with 1 brand: Bestochem. As per MCA filings, the company has open charges of ₹16.17 Cr and satisfied charges of ₹32.83 Cr on record. Court records list 30 cases involving the company, including 29 filed by the company and 1 filed against it; 5 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2 Cr; the latest was in December 2018. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Merril Pharma Private Limited with revenue of ₹66.57 Cr.
Bestochem Formulations (India) Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0004818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bestochem.com.
Company details
CIN U33119DL1985PLC022036
Registration Number 022036
Incorporation Date 18 September 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-56-0004818
Recognitions & Rankings of Bestochem Formulations (India)
Contact details
Bestochem Formulations (India) Limited's registered office is in New Delhi, Delhi. Its website is bestochem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 54 Vikas Marglaxmi Nagar, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bestochem Formulations (India) Limited, buy the company report.
Comprehensive company report
Bestochem Formulations (India) Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bestochem Formulations (India) operates one associated brand: Bestochem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies affordable pharmaceutical products in India. | bestochem.com |
Business activity
The main business activity of Bestochem Formulations (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bestochem Formulations (India) Limited, buy the company report.
Financials of Bestochem Formulations (India) Limited
FY 2025 filings availableBestochem Formulations (India) Limited reported revenue of ₹66.17 Cr (up 5% YoY) for FY 2024.
Revenue · FY 2024
₹66.17 Cr ▲ 5%
Net profit · FY 2024
₹2.47 Cr margin 3.7%
EBITDA · FY 2024
₹4.11 Cr margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 10%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▲ 22%
5 years · compounded
▼ 1%
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.47 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bestochem Formulations (India) Limited, buy the company report.
Board of directors of Bestochem Formulations (India) Limited
Bestochem Formulations (India) has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Greesh Kumar Juneja Also directs: Quality Bestochem Formulations Private Limited, Salute Bestochem Private Limited, Bigbrother Nutra Care Private Limited and 5 more | Director | 01 Aug 1986 | 40 Years 3 Months | Current |
| Anita Juneja Also directs: Petal Pharma Private Ltd, G. A. Davai India Private Limited, Newday Nutra Health Private Limited and 1 more | Director | 15 Feb 2005 | 21 Years 8 Months | Current |
| Urmila Prakash | Director | 01 Dec 1991 | 34 Years 11 Months | Current |
| Vijay Prakash Also directs: Quality Bestochem Formulations Private Limited, Salute Bestochem Private Limited, Bigbrother Nutra Care Private Limited and 3 more | Director | 18 Sep 1985 | 41 Years 1 Months | Current |
Peer comparison
Bestochem Formulations (India) Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Merril Pharma Private Limited | ₹66.57 Cr (FY 2025) | 25.0% | Ahmedabad, Gujarat, India | |||
| Hiral Labs Limited | ₹66.46 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Skyec Drugs and Pharmaceuticals Private Limited | ₹66.27 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Medizen Labs Private Limited | ₹66.2 Cr (FY 2023) | 39.0% | Bangalore, Karnataka, India | |||
| Bestochem Formulations (India) Limitedthis company | ₹66.17 Cr (FY 2024) | ₹2.47 Cr | 3.7% | 5.0% | New Delhi, Delhi, India | |
| Maxmed Life Sciences Private Limited | ₹66.13 Cr (FY 2023) | -10.0% | Delhi, India | |||
| Skymap Healthcare Private Limited | ₹65.96 Cr (FY 2022) | 70.0% | New Delhi, Delhi, India | |||
| Caplet India Pvt.Ltd. | ₹65.86 Cr (FY 2025) | -5.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Bestochem Formulations (India) Limited, buy the company report.
Auditor
Bestochem Formulations (India) Limited is audited by SANJAY PARWANDA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY PARWANDA & CO. | FY 2023 | 011274C |
Shareholding
The shareholding of Bestochem Formulations (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bestochem Formulations (India) Limited, buy the company report.
Charges & borrowings
Open charges
₹16.17 Cr
Satisfied charges
₹32.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2015 | 10602786 | Hdfc Bank Limited | ₹16.17 Cr | Open | |
| 29 Dec 2016 | 100072864 | Others | ₹4 Cr | Satisfied | |
| 06 Mar 2012 | 10345285 | Allahabad Bank | ₹35 Lakh | Satisfied | |
| 06 Mar 2012 | 10345311 | Allahabad Bank | ₹35 Lakh | Satisfied | |
| 29 Jul 2008 | 10118706 | Allahabad Bank | ₹1.25 Cr | Satisfied |
To see the full charge records of Bestochem Formulations (India) Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Bestochem Formulations (India) Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2 Cr; the latest was in December 2018.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹2 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2011 | Funding round | ₹2 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bestochem Formulations (India) Limited has 30 court cases on record: 29 filed by Bestochem Formulations (India), 1 filed against it. 5 cases are pending and 25 are disposed.
Total cases
30
Filed by the company
29
Filed against the company
1
Pending
5
Disposed
25
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 28 | 1 | 5 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Commercial suit | Filed by the company against Valfrid Pharmaceuticals Pvt Ltd | Disposed |
| District court, Meerut, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Meerut, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Meerut, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Meerut, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of Bestochem Formulations (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Bestochem Formulations (India) Limited was last rated by Brickwork on 18 Nov 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 18 Nov 2019 |
To see the full credit ratings and regulatory alerts of Bestochem Formulations (India) Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bestochem Formulations (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bestochem Formulations (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCB2139E1Z1 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bestochem Formulations (India) Limited, buy the company report.
Recent activity
Bestochem Formulations (India) Limited has 4 board changes on record since 1985: 4 appointments. The latest: Anita Juneja was appointed as Director on 15 Feb 2005.
AGM
Bestochem Formulations (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bestochem Formulations (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 29 Dec 2016 via Charge ID 100072864 with Others was fully satisfied on 17 Mar 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 16.17 Cr registered on 28 Oct 2015 with Charge ID 10602786 was modified on 16 Oct 2020.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100072864 was registered on 29 Dec 2016.
Charges
A charge registered on 06 Mar 2012 via Charge ID 10345285 with Allahabad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge registered on 06 Mar 2012 via Charge ID 10345311 with Allahabad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge registered on 29 Jul 2008 via Charge ID 10118706 with Allahabad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge registered on 31 Oct 2007 via Charge ID 10076054 with Allahabad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge registered on 01 Mar 2005 via Charge ID 80005893 with Allahbad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge registered on 22 Feb 2005 via Charge ID 80005894 with Allahabad Bank was fully satisfied on 19 Dec 2015.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.17 Cr with Charge ID 10602786 was registered on 28 Oct 2015.
14 earlier events are in the company report.
Frequently asked questions
Bestochem Formulations (India) is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 1985 (41+ years old) and is registered under CIN U33119DL1985PLC022036.
Bestochem Formulations (India) has 4 current directors:
- Greesh Kumar Juneja - Director
- Anita Juneja - Director
- Urmila Prakash - Director
- Vijay Prakash - Director
The latest financial statements of Bestochem Formulations (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bestochem Formulations (India) is 09AACCB2139E1Z1, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bestochem Formulations (India) is U33119DL1985PLC022036. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bestochem Formulations (India) has 30 court cases on record: 29 filed by the company and 1 filed against it. 5 are pending. Most are in the district courts.
Bestochem Formulations (India) was incorporated on 18 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Bestochem Formulations (India) has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2 Cr; the latest was in December 2018.
The peers of Bestochem Formulations (India) by revenue are Merril Pharma Private Limited, Hiral Labs Limited, Skyec Drugs and Pharmaceuticals Private Limited, Medizen Labs Private Limited, Maxmed Life Sciences Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anita Juneja was appointed as Director on 15 Feb 2005. Urmila Prakash was appointed as Director on 01 Dec 1991. Greesh Kumar Juneja was appointed as Director on 01 Aug 1986. Bestochem Formulations (India) has 4 board changes on record in total.
Yes, Bestochem Formulations (India) is registered as a small enterprise under Udyam registration (number: UDYAM-UP-56-0004818).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages